Macquarie Group Ltd - Dec 31, 2024 SCHEDULE 13G/A Report for Travere Therapeutics Inc Common Shares (TVTX)

Filing Manager
MACQUARIE GROUP LTD
Reporting Manager
Macquarie Group Limited
Security
Travere Therapeutics Inc Common Shares
Symbol
TVTX
Shares outstanding
86.9M shares
Disclosed Ownership
4.26M shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Date filed
2/7/2025, 07:44 AM
Date of event
Dec 31, 2024
Next filing
May 15, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Macquarie Group Limited 4.9% 4.26M 0 0 /s/ Philip Alexander Associate Director
Macquarie Management Holdings Inc 4.9% 4.26M 4.26M 0 /s/ Marty Wolin Chief Compliance Officer
Macquarie Investment Management Business Trust 4.9% 4.26M 4.26M 0 /s/ Marty Wolin Chief Compliance Officer